Cargando…
A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA)
BACKGROUND: Most patients suffering from a primary brain tumor (PBT) complain of chronic fatigue affecting their quality of life (QOL). We hypothesized that dexamphetamine sulfate, a psychostimulant drug, could improve fatigue in PBT patients. METHODS: A double-blind, phase III, multi-institutional,...
Autores principales: | Laigle-Donadey, Florence, Ducray, François, Boone, Matthieu, Diallo, Mamadou Hassimiou, Hajage, David, Ramirez, Carole, Chinot, Olivier, Ricard, Damien, Delattre, Jean-Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212857/ https://www.ncbi.nlm.nih.gov/pubmed/32642669 http://dx.doi.org/10.1093/noajnl/vdz043 |
Ejemplares similares
-
An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas
por: Laffaire, Julien, et al.
Publicado: (2014) -
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
por: Ducray, François, et al.
Publicado: (2010) -
Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline
por: Martz, Nicolas, et al.
Publicado: (2023) -
Pharmacokinetics of a Modified-Release Dexamphetamine Sulfate Formulation Following Single and Multiple Dosing in Healthy Adults: Comparative Bioavailability with Immediate-Release Dexamphetamine Sulfate, between Strengths, Assessment of Food and Meal Composition Effects
por: Sandersleben, Henrik Uebel-von, et al.
Publicado: (2023) -
Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)
por: Reyes‐Botero, Germán, et al.
Publicado: (2018)